
Novo Nordisk is an international pharmaceutical company headquartered in Denmark, with more than 90 years of experience in the innovation of solutions for the treatment of diabetes. Novo Nordisk is committed to research and development of treatments for hemophilia care, treatment with growth hormone and hormone replacement therapy.Novo Nordisk employs about 41,500 employees in 75 countries and is present with its products in more than 180 countries worldwide.
Novo Nordisk has Sales and Marketing operations in Italy, headquartered in Rome.
Contact
NOVO NORDISK SPA
Via Elio Vittorini, 129
00144 Rome (Italy)
Tel. +39 06.500881